Category: Off-label Use / Prescribing
-
Natrecor “Dear Doctor” Letter Seeks to Address Recent Safety Concerns
Letter Includes New Natrecor Label Revised in April 2005 Natrecor is a treatment, administered by injection, for patients with acutely decompensated congestive heart failure (ADHF) with dyspnea. Recent reports in medical journals have raised…
-
Natrecor Linked to Increased Death Rates and Kidney Problems
Medical Journals Raised Questions about Safety of Natrecor Natrecor has been reported to increase kidney problems and death rates among patients in recent editions of Circulation and The Journal of the American Medical Association…